Provided by Tiger Fintech (Singapore) Pte. Ltd.

Baudax Bio, Inc.

0.0218
0.0000
Volume:- -
Turnover:- -
Market Cap:950.33K
PE:-0.01
High:0.0218
Open:0.0218
Low:0.0218
Close:0.0218
52wk High:0.0218
52wk Low:0.0218
Shares:43.59M
Float Shares:43.59M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9085
EPS(LYR):-177.2990
ROE:-4704.21%
ROA:-114.93%
PB:-0.09
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Baudax Bio, Inc.
Exchange:
PINK
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.